Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.51
(0.73%)
CNY 5.51
(0.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -43.72 Million CNY | 16.39% |
| 2022 | -52.29 Million CNY | -19.68% |
| 2021 | -43.69 Million CNY | 61.66% |
| 2020 | -113.96 Million CNY | 9.44% |
| 2019 | -125.84 Million CNY | 64.48% |
| 2018 | -354.31 Million CNY | -199.67% |
| 2017 | -118.23 Million CNY | 28.49% |
| 2016 | -165.33 Million CNY | -80.66% |
| 2015 | -91.52 Million CNY | 22.2% |
| 2014 | -117.62 Million CNY | 47.0% |
| 2013 | -221.94 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -104.59 Million CNY | 23.66% |
| 2024 Q2 | -136.08 Million CNY | -242.18% |
| 2024 Q1 | -39.77 Million CNY | 9.04% |
| 2023 Q4 | -43.72 Million CNY | -15.8% |
| 2023 FY | -43.72 Million CNY | 16.39% |
| 2023 Q3 | -37.75 Million CNY | 74.4% |
| 2023 Q1 | -44.46 Million CNY | 14.98% |
| 2023 Q2 | -147.5 Million CNY | -231.74% |
| 2022 Q2 | -63.97 Million CNY | -21.69% |
| 2022 FY | -52.29 Million CNY | -19.68% |
| 2022 Q1 | -52.57 Million CNY | -20.31% |
| 2022 Q4 | -52.29 Million CNY | -110.31% |
| 2022 Q3 | -24.86 Million CNY | 61.13% |
| 2021 Q2 | -179.79 Million CNY | -72.36% |
| 2021 Q3 | -82.52 Million CNY | 54.1% |
| 2021 Q4 | -43.69 Million CNY | 47.05% |
| 2021 Q1 | -104.31 Million CNY | 8.47% |
| 2021 FY | -43.69 Million CNY | 61.66% |
| 2020 FY | -113.96 Million CNY | 9.44% |
| 2020 Q4 | -113.96 Million CNY | -1.49% |
| 2020 Q3 | -112.29 Million CNY | 46.71% |
| 2020 Q2 | -210.72 Million CNY | -323.23% |
| 2020 Q1 | -49.78 Million CNY | 60.43% |
| 2019 Q4 | -125.84 Million CNY | 38.53% |
| 2019 FY | -125.84 Million CNY | 64.48% |
| 2019 Q2 | -191.75 Million CNY | -149.9% |
| 2019 Q3 | -204.73 Million CNY | -6.77% |
| 2019 Q1 | 384.31 Million CNY | 208.47% |
| 2018 FY | -354.31 Million CNY | -199.67% |
| 2018 Q4 | -354.31 Million CNY | 0.0% |
| 2017 Q1 | -36.86 Million CNY | 77.7% |
| 2017 Q4 | -118.23 Million CNY | 0.0% |
| 2017 FY | -118.23 Million CNY | 28.49% |
| 2017 Q2 | -36.86 Million CNY | 0.0% |
| 2016 Q1 | -112.94 Million CNY | 0.0% |
| 2016 Q2 | -112.94 Million CNY | 0.0% |
| 2016 Q3 | -165.33 Million CNY | -46.39% |
| 2016 Q4 | -165.33 Million CNY | 0.0% |
| 2016 FY | -165.33 Million CNY | -80.66% |
| 2015 FY | -91.52 Million CNY | 22.2% |
| 2014 FY | -117.62 Million CNY | 47.0% |
| 2013 FY | -221.94 Million CNY | 0.0% |